Zobrazeno 1 - 10
of 24
pro vyhledávání: '"AK Dunbier"'
Publikováno v:
Cancer Research. 72:P4-06
Background: Genome wide association studies have identified single nucleotide polymorphisms around C6ORF97, an open reading frame (ORF) immediately upstream of the gene encoding ERα (ESR1) on 6q25.1, to be associated with increased risk of breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::218cc8b2e4b672252918811f28ce4672
https://doi.org/10.1158/0008-5472.sabcs12-p4-06-11
https://doi.org/10.1158/0008-5472.sabcs12-p4-06-11
Autor:
AK Dunbier, H Anderson, E Folkerd, Z Ghazoui, IE Smith, MJ Ellis, M Dowsett, Neoadjuvant Letrozole Study Group
Publikováno v:
Cancer Research. 69:63
Abstract #63 Background: Estrogen exposure is linked to the development and treatment of the majority of breast cancers. High estradiol (E2) levels are associated with elevated breast cancer risk in postmenopausal women and estrogen antagonism or wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddd0780a92776d481ff0f8688cb18f0c
https://doi.org/10.1158/0008-5472.sabcs-63
https://doi.org/10.1158/0008-5472.sabcs-63
Autor:
McGuinness CF; Department of Biochemistry, University of Otago, Dunedin, New Zealand.; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Black MA; Department of Biochemistry, University of Otago, Dunedin, New Zealand., Dunbier AK; Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Dec; Vol. 12 (23), pp. 21545-21560. Date of Electronic Publication: 2023 Nov 17.
Autor:
Hazlett J; Department of Biochemistry, University of Otago, Dunedin, New Zealand. jody.hazlett@otago.ac.nz., Niemi V; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand., Aiderus A; Department of Biochemistry, University of Otago, Dunedin, New Zealand., Powell K; Department of Biochemistry, University of Otago, Dunedin, New Zealand., Wise L; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand., Kemp R; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand., Dunbier AK; Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2021 Oct 03; Vol. 23 (1), pp. 95. Date of Electronic Publication: 2021 Oct 03.
Autor:
McMillan HD; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand., Keeshan K; Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Scotland G12 0YN, UK., Dunbier AK; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand., Mace PD; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Jun 19; Vol. 13 (12). Date of Electronic Publication: 2021 Jun 19.
Autor:
Jamieson SA; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, 710 Cumberland Street, Dunedin 9054, New Zealand., Ruan Z; Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA., Burgess AE; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, 710 Cumberland Street, Dunedin 9054, New Zealand., Curry JR; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, 710 Cumberland Street, Dunedin 9054, New Zealand., McMillan HD; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, 710 Cumberland Street, Dunedin 9054, New Zealand., Brewster JL; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, 710 Cumberland Street, Dunedin 9054, New Zealand., Dunbier AK; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, 710 Cumberland Street, Dunedin 9054, New Zealand., Axtman AD; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Kannan N; Institute of Bioinformatics, University of Georgia, Athens, GA 30602, USA.; Department of Biochemistry & Molecular Biology, University of Georgia, Athens, GA 30602, USA., Mace PD; Biochemistry Department, School of Biomedical Sciences, University of Otago, P.O. Box 56, 710 Cumberland Street, Dunedin 9054, New Zealand. peter.mace@otago.ac.nz.
Publikováno v:
Science signaling [Sci Signal] 2018 Sep 25; Vol. 11 (549). Date of Electronic Publication: 2018 Sep 25.
Autor:
Aiderus A; Centre for Translational Cancer Research and Department of Biochemistry, University of Otago, Dunedin, 9054, New Zealand., Black MA; Centre for Translational Cancer Research and Department of Biochemistry, University of Otago, Dunedin, 9054, New Zealand., Dunbier AK; Centre for Translational Cancer Research and Department of Biochemistry, University of Otago, Dunedin, 9054, New Zealand. anita.dunbier@otago.ac.nz.
Publikováno v:
BMC cancer [BMC Cancer] 2018 Aug 09; Vol. 18 (1), pp. 805. Date of Electronic Publication: 2018 Aug 09.
Autor:
Prat A; Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain. alprat@clinic.ub.es.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Lluch A; Department of Medical Oncology, Valencia University Hospital, Valencia, Spain., Turnbull AK; University of Edinburgh Cancer, Research UK Centre, Edinburgh., Dunbier AK; Department of Biochemistry, University of Otago, Dunedin, New Zealand., Calvo L; Department of Medical Oncology, A Coruña University Hospital Complex, A Coruña, Spain., Albanell J; Department of Medical Oncology, Hospital del Mar Medical Research Institute-IMIM and Pompeu Fabra University, Barcelona, Spain., de la Haba-Rodríguez J; Department of Medical Oncology, Biomedical Research Institute-IMIBIC, Reina Sofía Hospital Complex, Córdoba, Spain., Arcusa A; Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain., Chacón JI; Department of Medical Oncology, Virgen de la Salud Hospital, Toledo, Spain., Sánchez-Rovira P; Department of Medical Oncology, Jaén Hospital Complex, Jaen, Spain., Plazaola A; Department of Medical Oncology, Onkologikoa, Donostia, Spain., Muñoz M; Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Paré L; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Parker JS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Ribelles N; Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain., Jimenez B; Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain., Bin Aiderus AA; University of Edinburgh Cancer, Research UK Centre, Edinburgh., Caballero R; GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain., Adamo B; Department of Medical Oncology, Hospital Clínic i Provincial, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Dowsett M; Academic Department of Biochemistry, Royal Marsden Foundation Trust, London, United Kingdom., Carrasco E; GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain., Martín M; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain., Dixon JM; University of Edinburgh Cancer, Research UK Centre, Edinburgh., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.; Department of Genetics, University of North Carolina, Chapel Hill, North Carolina.; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina., Alba E; Department of Medical Oncology, Virgen de la Victoria University Hospital, Málaga, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Jun 15; Vol. 23 (12), pp. 3035-3044. Date of Electronic Publication: 2016 Nov 30.
Autor:
Turnbull AK; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand., Arthur LM; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand., Renshaw L; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand., Larionov AA; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand., Kay C; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand., Dunbier AK; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand., Thomas JS; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand., Dowsett M; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand., Sims AH; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand. andrew.sims@ed.ac.uk., Dixon JM; Arran K. Turnbull, Laura M. Arthur, Lorna Renshaw, Alexey A. Larionov, Charlene Kay, Jeremy S. Thomas, Andrew H. Sims, J. Michael Dixon, University of Edinburgh Cancer Research UK Centre, Edinburgh; Anita K. Dunbier, Mitch Dowsett, Institute of Cancer Research, London, United Kingdom; and Anita K. Dunbier, University of Otago, Dunedin, New Zealand.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2015 Jul 10; Vol. 33 (20), pp. 2270-8. Date of Electronic Publication: 2015 Jun 01.
Autor:
López-Knowles E; Royal Marsden Hospital, London, UK. elena.lopez-knowles@icr.ac.uk.; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. elena.lopez-knowles@icr.ac.uk., Wilkerson PM; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. paul.wilkerson@icr.ac.uk., Ribas R; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. ricardo.ribas@icr.ac.uk., Anderson H; Royal Marsden Hospital, London, UK. helenlanderson@btinternet.com.; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. helenlanderson@btinternet.com., Mackay A; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. alan.mackay@icr.ac.uk., Ghazoui Z; Royal Marsden Hospital, London, UK. zara.ghazoui@astrazeneca.com.; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. zara.ghazoui@astrazeneca.com.; Current affiliation: AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK. zara.ghazoui@astrazeneca.com., Rani A; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. aradhana.rani@icr.ac.uk., Osin P; Royal Marsden Hospital, London, UK. peter.osin@rmh.nhs.uk., Nerurkar A; Royal Marsden Hospital, London, UK. ashutosh.nerurkar@rmh.nhs.uk., Renshaw L; University of Edinburgh, Edinburgh, UK. Lorna.Renshaw@luht.scot.nhs.uk., Larionov A; University of Edinburgh, Edinburgh, UK. al720@medschl.cam.ac.uk.; Current affiliation: Academic Laboratory of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK. al720@medschl.cam.ac.uk., Miller WR; University of Edinburgh, Edinburgh, UK. bill@aromil.co.uk., Dixon JM; University of Edinburgh, Edinburgh, UK. mike.dixon@ed.ac.uk., Reis-Filho JS; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. reisfilj@mskcc.org.; Current affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA. reisfilj@mskcc.org., Dunbier AK; Royal Marsden Hospital, London, UK. anita.dunbier@otago.ac.nz.; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. anita.dunbier@otago.ac.nz.; Current affiliation: Department of Biochemistry, University of Otago, Dunedin, New Zealand. anita.dunbier@otago.ac.nz., Martin LA; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. Lesley-Ann.Martin@icr.ac.uk., Dowsett M; Royal Marsden Hospital, London, UK. Mitch.dowsett@icr.ac.uk.; Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK. Mitch.dowsett@icr.ac.uk.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2015 Mar 11; Vol. 17, pp. 35. Date of Electronic Publication: 2015 Mar 11.